Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate
Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia
Heat-shock protein vaccines as active immunotherapy against human gliomas
[The case of tumor escape mechanism by changing their tumor-associated antigens]
[Dendritic cell vaccine for intrahepatic cholangio cellular carcinoma–a study of relationship between immuno-reaction and clinical outcome]
Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccination
Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myeloma
Oncolytic virus therapy for prostate cancer
Engineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinoma
An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
Immunotherapy of diffuse gliomas: biological background, current status and future developments
Dendritic cell therapy of high-grade gliomas
Immunizing against breast cancer: a new swing for an old sword
Immunotherapy with dendritic cells pulsed by autologous dactinomycin-induced melanoma apoptotic bodies for patients with malignant melanoma
Dendritic cell-based cancer gene therapy
Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma
Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine
Enhanced T-cell activation by immature dendritic cells loaded with HSP70-expressing heat-killed melanoma cells
Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer
Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL